A $100,000 factor-weighted model portfolio yields about 4%, with several stocks trading near decade-high dividend yields.

The S&P 1500 Health Care Index gained 1.9% in September, underperforming the S&P 500, which advanced 3.7%. Read more here.

Healthcare giant Pfizer ( PFE 2.24%) has been offering a high yield for some time. But that hasn't been enough to get ...

PFE trades above its 50-day SMA on recent gains from the Metsera acquisition and a drug pricing agreement with the U.S.

Pfizer eventually increased its offer. The company is now set to acquire Metsera in a deal worth up to $10 billion, including ...

PepsiCo products are enjoyed by consumers more than one billion times a day in more than 200 countries and territories around the world. PepsiCo generated nearly $92 billion in net revenue in 2024, ...

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...

Corey and Christine will provide an update on the commercial launch of Orlynda in the U.S. Corey will also give an update on ...

The Biotech Growth Trust PLC - Half-year Financial Report ...

The global myelofibrosis market is on the rise, driven by advancements in JAK inhibitors, increasing awareness, and early diagnosis efforts. Myelofibrosis, a rare bone marrow cancer, affects blood ...

Consumer staples like Coca-Cola as well as healthcare and industrial stocks should hold up well. But don’t abandon tech just yet. The downbeat mood on Wall Street could be a great opportunity to buy ...